نتایج جستجو برای: triptorelin

تعداد نتایج: 235  

2016
Yu Li Ping Pan Ping Yuan Qi Qiu Dongzi Yang

BACKGROUND Resistant ovary syndrome (ROS) is a rare endocrine disorder characterized with hypergonadotrophic hypogonadism. Infertility is a common complaint of woman presenting with ROS, and little progress has been made in term of reproduction with the patient's own gamete. So far only one case report of live birth has been reported after in vitro maturation (IVM) of oocytes in a patient suffe...

Journal: :Anticancer research 2006
R Torrisi L Orlando R Ghisini P Veronesi M Intra A Rocca A Balduzzi A Cardillo A Goldhirsch M Colleoni

BACKGROUND Dose-dense chemotherapy with anthracyclines and taxanes has improved either disease free survival or overall survival in high risk patients with early breast cancer. PATIENTS AND METHODS The activity and safety of a dose-dense schedule (q14 days) of adriamycin 60 mg/sqm and cyclophosphamide 600 mg/sqm (AC) x 4 cycles followed by docetaxel 75 mg/sqm for 4 cycles with hematopoietic s...

Journal: :International journal of clinical and experimental medicine 2015
Ying Jin Yan Li Cheng-Yan Deng Qin-Jie Tian Hao Chen Ling-Ya Pan

Low-grade endometrial stromal sarcoma (ESS) is a kind of uterine malignancy. Total hysterectomy and bilateral salpingo-oophorectomy was the main treatment. We evaluate the feasibility of fertility-sparing management in five patients with low-grade ESS who desired for childbearing. The patients aged 28-36 years old presented with symptoms of menometrorrhagia or without symptom. Ultrasound examin...

Journal: :Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 2013
Marina T Bergoglio Marcelino Gómez-Balaguer Elena Almonacid Folch Felipe Hurtado Murillo Antonio Hernández-Mijares

Transsexualism is defined as a strong conviction of belonging to the opposite sex in individuals without any physical intersex condition. Cross-sex hormone therapy is an important component of medical treatment of transexuals but it is not exempt from adverse effects. We report a case of a meningioma in a male-to-female transsexual patient treated with estrogens and cyproterone acetate for the ...

2017
Maryam Eftekhar Maryam Farid Mojtahedi Sepideh Miraj Malihe Omid

Background Gonadotropin-releasing hormone agonists (GnRH-a) was increasingly used for triggering oocyte maturationfor the prevention of ovarian hyperstimulation syndrome. Studies suggest that GnRH-a might be used as a better trigger agent since it causes both Luteinizing hormone and follicle stimulating hormone release from a physiologic natural cycle. Objective The aim of this study was to e...

Journal: :Diagnostic and Therapeutic Endoscopy 1995
L. Mettler E. Alvarez-Rodas K. Semm

In cases of benign lesions, pelviscopy is used in about 70% of all abdominal operations at our Department of Obstetrics and Gynecology. From 1990 to 1992, 851 patients with myomas were treated by surgery. In 57% pelviscopy, in 2% laparotomy, and in 1% hysteroscopic myomectomies were treated. In 11%, a CISH (Classical Intrafascial SEMM-serrated edged macro morcellator-Hysterectomy) without colpo...

Journal: :Reproductive biomedicine online 2005
Shahar Kol Mira Muchtar

Ovarian stimulation of the high responder remains controversial. The narrow margin between a too low gonadotrophin dose (and abnormal oestradiol rise) and excessive stimulation (risk of OHSS) is a challenging situation. This study describes an OHSS-free protocol, based on the use of recombinant gonadotrophins for stimulation and gonadotrophin-releasing hormone (GnRH) antagonist to prevent prema...

Journal: :Acta clinica Croatica 2017
Miro Kasum Slavko Orešković Daniela Franulić Ermin Čehić Albert Lila Goran Vujić Franjo Grgić

The purpose of this review is to analyze current medical strategies in the prevention of ovarian hyperstimulation syndrome (OHSS) during ovarian stimulation for in vitro fertilization. Owing to contemporary preventive measures of OHSS, the incidence of moderate and severe forms of the syndrome varies between 0.18% and 1.40%. Although none of medical strategies is completely effective, there is ...

Journal: :international journal of reproductive biomedicine 0
robab davar maryam farid mojtahedi sepideh miraj

background: there is no doubt that luteal phase support is essential to enhance the reproductive outcome in ivf cycles. in addition to progesterone and human chorionic gonadotropin, several studies have described gnrh agonists as luteal phase support to improve implantation rate, pregnancy rate and live birth rate, whereas other studies showed dissimilar conclusions. all of these studies have b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید